Get started

Medicaldevices

Bullish Charts - Golden CrossBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. Daily Chart - Golden Cross Stochastic is moving up, Bullish RSI is crossing center line, Bullish Volume just went green on the daily I think the stock is getting ready to move higher. I also think, BSX is one of the cheapest medical device companies in the industry. Long
NYSE:BSXLong
by HotCharts
$VIVE Classic "Cursed After Reversed" Or Can It ReVIVE Itself?VIVE seems like it can't get out of its own way. Great gap up in the morning but yet again, another red close. Even after reversing, shares are back at penny stock levels. So is it doomed to repeat history or can it find a new bottom? I don't know if anyone really knows for sure just yet. "Viveve’s stock price had a terrible September, dropping more than 57%. However, its start to October is looked promising at the start. The healthcare penny stock gapped up over 25% during premarket hours on October 1st. In addition, the penny stock has already tripled its average trading volume. But as you see, VIVE stock has pulled back considerably from those premarket highs."* *Quote Source: 5 Money Making Penny Stocks To Watch This Week Most Recent News: Viveve Raises $6.76 million Through Completion of At-The-Market Equity Financing ENGLEWOOD, CO / ACCESSWIRE / October 1, 2019 / Viveve Medical, Inc. (VIVE), a medical technology company focused on women's intimate health, today announced the completion of its at-the-market (ATM) offering of $6.76 million of shares of its common stock with Ladenburg Thalmann & Co. Inc. as the sales agent. The company sold 1,004,171 shares at a weighted average price of $6.73 per share (adjusting for a reverse stock split of Viveve common stock effected September 18, 2019) resulting in net proceeds of approximately $6.56 million to the company after deduction of sales commissions. As of September 30, 2019, the company had 1,469,589 shares outstanding. About VIVE Viveve Medical, Inc. is a medical technology company focused on women's intimate health. Viveve is committed to advancing new solutions to improve women's overall well-being and quality of life. The internationally patented Viveve® System incorporates cryogen-cooled monopolar radiofrequency (CMRF) technology to uniformly deliver volumetric heating while gently cooling surface tissue to generate neocollagenesis in a single in-office session. News Source: finance.yahoo.com
V
by PennyStocks101
1
Corindus Vascular Robotics Inc. - NYSE: $CVRS ConsolidatingTECHNICAL After breaking-out in early Spring (March) and subsequently digesting the move, CVRS broke-out once again last month (May) on enormous volume and now finds itself consolidating in a very constructive manner on lower volume as evidenced in the Daily chart above. With the stock trading just beneath its 20 DMA, yet comfortably above both its 50 and 200 DMA's, the technical picture remains positive, while the recent move into northern territory is absorbed. With that said, it now appears that it is only a matter of time before CVRS embarks on yet another potential leg higher. Thus, both investors/traders may want to continue to monitor the action closely in the days/weeks ahead as the recent consolidation comes to a conclusion with a possible break for greener pastures and a move topside of 3.10 likely triggering its next meaningful advance.
C
by InsiderFinancial
AIT THERAPEUTICS INC - NASDAQ: $AITB Waking UpAfter breaking to higher ground last month and subsequently consolidating/digesting the move, it appears that AIT THERAPEUTICS INC - NASDAQ:AITB is starting to wake-up once again as yesterday's action indicates when observing the Daily chart above. With the stock trading above all of its important moving averages 20/50/200 DMA's, AITB finds itself in a technically healthy posture. While there is no doubt that AITB is 'Thinly' traded, it certainly appears that buyers came into the stock yesterday and we may just witness some follow-through in the days/weeks ahead. Thus, both investors/traders may want to continue to monitor the action in AITB for additional clues/evidence with regards to potential further advance moving forward. Should AITB be capable of clearing the $6.25 hurdle at any point moving forward, we may just witness a move into the $9 - $10 zone.
A
by InsiderFinancial